He decides to become a research student in Cambridge.
A radio factory is built on the location which would later become the Max Perutz Labs and the VBC 6.
Max F. Perutz and John C. Kendrew receive the Nobel Prize for Chemistry for their studies of globular proteins.
Pharmaceutical companies Boehringer Ingelheim and Genentech decide to found a basic research institute and can be convinced to choose Vienna. The agreement includes to move related university institutes to the new location in St. Marx in Vienna's third district to kick-start a bio-center.
The newly established Vienna BioCenter takes over an area that has seen an eventful past. It was once the gate to the medieaval city, the location of a brewery, a hospital for the poor and, most recently, the location of the city's slaughterhouse.
The construction of the new university building, which will later become the Max F. Perutz Laboratories, is finished, adding a new landmark to the Vienna BioCenter.
Max Perutz dies in Cambridge at the age of 88. His legacy in establishing the research field of Molecular Biology continues to live on in science today.
Researchers from the University of Vienna, the Medical University with the support of policy makers agree to establish an internationally competitive research institute.
Gisela Perutz, Max's Widow, grants permission to name the new research institute after her late husband.
The Max F. Perutz Laboratories are established in honour of an extraordinary teacher and scientist.
Graham Warren is appointed as the first Scientific Director of the Max F. Perutz Laboratories. His strategy of attracting young, competitive, and highly motivated researchers shapes the future of the institute.
Group leader Emmanuelle Charpentier and her team publish - in conjunction with Jennifer Doudna’s group at Berkeley - a breakthrough study that reveals the molecular mechanism of the type II CRISPR system. The implications for genome engineering are enormous.
The 100th birthday of Max Perutz is celebrated with the "Crossing Frontiers in Life Sciences" symposium in Vienna. Internationally renowned scientists and Max F. Perutz Laboratories researchers talk about structural biology, cell signalling, bioinformatics, RNA biology, and chromosome dynamics.
10 years after its foundation the Max F. Perutz Laboratories boast an impressive track record of prestigous research awards: 6 ERC Starting grants, 1 ERC Consolidator grant, 4 WWTF Young Investigators grants, 5 START Prizes, 7 EMBO Memberships, 3 EMBO Young Investigators and 3 Human Frontier in Science Program (HFSP) grants.
Arndt von Haeseler is appointed Scientific Director.
MFPL starts the "Catalyzing Change" process, leading the Max Perutz Labs into a new era of research in mechanistic biomedicine.
Renaming MFPL to Max Perutz Labs Vienna is a symbol for the institute upholding the values Max Perutz stands for: creating an open environment where ideas can be exchanged and international researchers can thrive. It also symbolizes the institute's dedication to a mechanistic understanding of important biological processes - with the potential to catalyze groundbreaking discoveries in mechanistic biomedicine.
Alwin Köhler is appointed Scientific Director.
The Max Perutz Labs are rebuilding key parts of the institute. The opening of the new entrance, reception, and study space for students marks a first milestone of a major project that will provide creative space for researchers to meet and to discuss ideas.
The “Max Bar” pop-up café creates a room where new ideas and collaborations can arise from spontaneous, informal discussions over a coffee break.
"Breathing at High Altitude" – an exhibition about the life and science of Max Perutz opens its doors. The project was initiated by the Max Perutz Labs with the goal of sparking curiosity among the broader public about this pioneer of molecular biology.
On the facade of the Max Perutz Labs the artist duo Käthe Schönle and Sebastian Schager, in collaboration with the art & science project ‘WIENERWISSEN’, created a large mural picturing the Austrian-British Nobel Prize winner Max Perutz.